Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	MRNAModerna	BIIBBiogen	ONCBeOne Medicines AG
Snapshot
Price	$182.52	$225.31	$365.95
Market cap	$31.65B	$31.91B	$33.43B
Valuation
P/E	—	24.2x	71.9x
Forward P/E	—	26.3x	—
Growth
Revenue growth	-30.0%	1.2%	36.2%
EPS growth	—	-8.1%	—
Profitability
Net margin	-143.6%	13.8%	7.8%
ROE	-36.7%	7.5%	5.2%
Balance sheet & cash
Debt / equity	0.07x	0.34x	0.25x
Free cash flow yield	-13.6%	6.8%	—
Dividend yield	—	—	—
Verdict
Investment rating	Weak· 17	Neutral· 49	Neutral· 48

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	MRNAtoday $183	BIIBtoday $225	ONCtoday $366
2027	$139.63 – $204.79+12% CAGR	$172.36 – $252.80+12% CAGR	$373.76 – $548.19+50% CAGR
2028	$142.42 – $208.88+7% CAGR	$175.81 – $257.85+7% CAGR	$508.99 – $746.52+43% CAGR
2029	$145.27 – $213.06+5% CAGR	$179.33 – $263.01+5% CAGR	$693.14 – $1,016.61+41% CAGR
2030	$148.17 – $217.32+4% CAGR	$182.91 – $268.27+4% CAGR	$943.92 – $1,384.42+39% CAGR
2031	$151.14 – $221.67+4% CAGR	$186.57 – $273.64+4% CAGR	$1,285.43 – $1,885.30+39% CAGR
5-yr CAGR	-3.7% – 4.0%	-3.7% – 4.0%	28.6% – 38.8%